Weekly NIH Funding Opportunity Announcement

Published Friday, April 14, 2017

Requests for Applications

Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43)
(RFA-AR-18-005)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): July 10, 2017, by 5:00 PM local time of applicant organization. Late applications will not be accepted. 

SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44)
(RFA-CA-17-024)
National Cancer Institute
Application Receipt Date(s): July 6, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) 
(RFA-DA-18-005)
National Institute on Drug Abuse
Application Receipt Date(s): June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

Identification of Reproductive-Tract Specific Proteins/Transcripts for the Development of Male and Female Non-Hormonal Contraceptives (R01)
(RFA-HD-18-002)
Eunice Kennedy Shriver National Institute of Child Health and Human Development 
Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

Point of Care Technologies for the Evaluation and Management of Obstetrics, Neonatal, and Pediatric Critical Care Patients, and for Patients with Disorders of Reproductive Tract and Infertility (R43) 
(RFA-HD-18-028)
Eunice Kennedy Shriver National Institute of Child Health and Human Development 
Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. 

Integrative Computational Biology for Analysis of NHLBI TOPMed Data (RFA-HL-18-020)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): July 6, 2017 and July 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Technologies to Understand the Control of Organ Function by the Peripheral Nervous System (OT2)
(RFA-RM-17-010)
NIH Roadmap Initiatives
National Center for Advancing Translational Sciences
The Common Fund/Office of Strategic Coordination
Application Receipt Date(s): New and resubmission applications are accepted on the date specified in the Invitation to Submit after successful competition of the corresponding OT1 pre-application (See RM-17-009) and must be submitted by 5:00 PM local time of the applicant. 

Program Announcements

NINDS Program Project Grant (P01)
(PAR-17-251) 
National Institute of Neurological Disorders and Stroke
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative R01)
(PAR-17-252) 
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (R01)
(PAR-17-253) 
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

Lasker Clinical Research Scholars Program Si2/R00
(PAR-17-254) 
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development 
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Application Receipt/Submission Date(s): August 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

Limited Competition: National Swine Resource and Research Center (U42)
(PAR-17-255) 
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt/Submission Date(s): June 21, 2017, September 25, 2017 and January 25, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

Collaborative R01s for Clinical Studies of Mental Illness Not Involving Clinical Trials (Collaborative R01)
(PAR-17-256) 
National Institute of Mental Health
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

Notices

Request for Information on the Development of the FY 2019 Trans-NIH Plan for HIV-Related Research
(NOT-OD-17-053) Office of AIDS Research

Notice of Correction for RFA-OD-17-002 "Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)" 
(NOT-OD-17-054) National Institutes of Health
Office of Disease Prevention

Notice of Correction for RFA-OD-17-006 "Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)" 
(NOT-OD-17-055) National Institutes of Health
Office of Disease Prevention

Guidance for Adjustments to Appointment Records in xTrain to Reflect Stipend Level Increases for Postdoctoral Trainees on Institutional Ruth L. Kirschstein National Research Service Awards (NRSA)
(NOT-OD-17-057) National Institutes of Health

Notice of Form Correction for PA-16-286 "Successor-in-Interest (Type 6 Parent)"
(NOT-OD-17-058) National Institutes of Health

Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers Research Centers (P50)
(NOT-AR-18-006)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Heart, Lung, and Blood Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development 
National Institute of Neurological Disorders and Stroke

Notice of Intent to Publish a Funding Opportunity Announcement for Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21)
(NOT-AR-18-007)
National Institute of Arthritis and Musculoskeletal and Skin Diseases

Notice of Informational Webinars for Investigators Applying for NCCIH Clinical Trials
(NOT-AT-17-009)
National Center for Complementary and Integrative Health

Notice of Change to Key Dates in PAR-16-111 "Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)" 
(NOT-CA-17-048)
National Cancer Institute

Notice of Pre-application Webinar for PAR-16-131 Emerging Questions in Cancer Systems Biology (U01)
(NOT-CA-17-049)
National Cancer Institute

Notice of Change in the Expiration Date for PA-14-162 "Effects of Cannabis Use and Cannabinoids on the Developing Brain (R21)"
(NOT-DA-17-017)
National Institute on Drug Abuse

Notice of Change in the Expiration Date for PA-14-164 "Effects of Cannabis Use and Cannabinoids on the Developing Brain (R03)"
(NOT-DA-17-018)
National Institute on Drug Abuse

Notice of Change in the Expiration Date for PA-14-163 "Effects of Cannabis Use and Cannabinoids on the Developing Brain (R01)"
(NOT-DA-17-019)
National Institute on Drug Abuse

Notice of Change in the Expiration Date for PA-14-083 "Neuroimmune Signaling and Function in Substance Use Disorders (R21)"
(NOT-DA-17-020)
National Institute on Drug Abuse

Notice of Change in the Expiration Date for PA-14-084 "Neuroimmune Signaling and Function in Substance Use Disorders (R01)"
(NOT-DA-17-021)
National Institute on Drug Abuse

Notice of Change in the Expiration Date for PAR-14-225 Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01) 
(NOT-DA-17-022)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Cancer Institute

Notice of Change in the Expiration Date for PA-15-099 "Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)"
(NOT-DA-17-023)
National Institute on Drug Abuse

RFP Notice: Pharmacokinetic and Pharmacodynamic Studies for Medications Development
(NOT-DA-17-062)
National Institute on Drug Abuse

Notice to Extend PAR-15-024 "Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01)
(NOT-DK-17-011)
National Institute of Diabetes and Digestive and Kidney Diseases

Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) 
(NOT-FD-17-007)
Food and Drug Administration

Notice of NICHD's Participation in PAR-17-221 "Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)" 
(NOT-HD-17-011)
Eunice Kennedy Shriver National Institute of Child Health and Human Development 

Correction for AHRQ Consumer Assessment of Healthcare Providers and Systems V (U18) FOA
(NOT-HS-17-012)
Agency for Healthcare Research and Quality

Request for Information (RFI): Input on Opportunities of Engagement of External Stakeholders With the Illuminating the Druggable Genome (IDG) Program
(NOT-RM-17-017)
NIH Roadmap Initiatives